A Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of the Safety of Rilonacept for the Prophylaxis of Gout Flares in Patients on Urate- Lowering Therapy
A Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of the Safety of Rilonacept for the Prophylaxis of Gout Flares in Patients on Urate- Lowering Therapy
The purpose of this clinical research study is to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are on urate-lowering therapy. Subjects will participate in this study for approximately 20 weeks. Rilonacept is being studied for use in preventing gout flares in subjects on urate-lowering therapy.
Inclusion Criteria:
Exclusion Criteria:
Monck's Corner, South Carolina, United States
Sugarland, Texas, United States
Secundrabad, Andh Prad, India
New Dehli, National Capital Territory of Delhi, India
South Sumatra, Indonesia
Limpopo, Gauteng, South Africa
Rustenburg, Gauteng, South Africa
Durban, Mpumalanga, South Africa